Followers | 11 |
Posts | 190 |
Boards Moderated | 0 |
Alias Born | 06/28/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 30, 2020 11:09:54 AM
Brilacidin is earning more attention because it's progressing thru RBL trials virtually free of charge, who would've imagined this a few months ago. In life, timing is everything. While we all hate what this virus has done to wreak havoc to mankind around the world, it is a cause of celebration to see it eliminated ASAP. Brilacidin could be a very effective single agent against COVID-19 when the dust settles or a very important combo agent.
If Brilacidin continues to show strong efficacy & safety in the more advanced trials at the RBL's, it will ultimately overcome all the doubters and dumpers and get the attention for partnership or a buyout. Shrewd big pharma/biotech who see and jump on the opportunity after successful RBL clinical trials against COVID-19 to include B-OM, B-IBD and also get Kevetrin would be very attractive... the stock will soar and could be the stock investment of the year!!!
Gilead's Remdesivir recent data (yesterday) is good progress as a single agent, not a home run, the death rate is not a great improvement vs. placebo... Maybe a Remdesivir and Brilacidin combo possibility in the future?
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM